High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 14, Issue -, Pages 3837-3848
Publisher
Informa UK Limited
Online
2021-09-17
DOI
10.2147/idr.s322803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study
- (2021) Yue Zheng et al. Frontiers in Medicine
- Bloodstream infections in critically ill patients: an expert statement
- (2020) Jean-François Timsit et al. INTENSIVE CARE MEDICINE
- Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections
- (2020) Guolian Xia et al. MEDICINE
- High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
- (2020) Xiang-Rong Bai et al. Infection and Drug Resistance
- Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
- (2019) Tianshui Niu et al. Antimicrobial Resistance and Infection Control
- Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study
- (2019) Alessandro Russo et al. JOURNAL OF INFECTION
- Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis
- (2019) Hekun Mei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
- (2018) Jeffrey Baron et al. Journal of Clinical Medicine
- Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
- (2018) Mohamed M. Ibrahim et al. Drug Design Development and Therapy
- Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
- (2018) Tianshui Niu et al. Infection and Drug Resistance
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- 490High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
- (2017) Sharon Sam et al. Open Forum Infectious Diseases
- The importance of source control in the management of severe skin and soft tissue infections
- (2016) Christian Eckmann CURRENT OPINION IN INFECTIOUS DISEASES
- Efficacy of Tigecycline for Secondary Acinetobacter Bacteremia and Factors Associated with Treatment Failure
- (2015) Bo-Huang Liou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance
- (2015) Sing-On Teng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study
- (2014) Hao Wang et al. BMC INFECTIOUS DISEASES
- A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia
- (2014) A. Nutman et al. CLINICAL MICROBIOLOGY AND INFECTION
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter Case-Case Control Study for Risk Factors and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2013) Tat Ming Ng et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
- (2012) M. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
- (2010) H. E. Davies et al. THORAX
- Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2009) Joseph S. Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
- (2009) April Barbour et al. CLINICAL PHARMACOKINETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started